Corazza P - Search Results

1

Influence of scleral thickness on photodynamic therapy outcomes in central serous chorioretinopathy.

Forte P, Cattaneo J, Cardillo Piccolino F, Arrigo A, Corazza P, Musetti D, Rosa R, Traverso CE, Fontana V, Lupidi M, Eandi CM, Nicolò M. Forte P, et al. Among authors: corazza p. Acta Ophthalmol. 2024 Oct 20. doi: 10.1111/aos.16779. Online ahead of print. Acta Ophthalmol. 2024. PMID: 39428607

2

Vascular Density and Retinal Function in Patients with Retinitis Pigmentosa Evaluated by Swept-Source OCT Angiography and Microperimetry.

Corazza P, Cirafici P, Testa V, Orlans HO, Berisso M, Traverso CE, Vagge A, Nicolò M. Corazza P, et al. Ophthalmologica. 2021;244(1):27-33. doi: 10.1159/000507961. Epub 2020 Apr 20. Ophthalmologica. 2021. PMID: 32305973

3

Choroidal changes in intermediate age-related macular degeneration patients with drusen or pseudodrusen.

Rosa R, Corazza P, Musolino M, Mochi C, Maiello G, Traverso CE, Nicolò M. Rosa R, et al. Among authors: corazza p. Eur J Ophthalmol. 2021 Mar;31(2):505-513. doi: 10.1177/1120672120914530. Epub 2020 Apr 27. Eur J Ophthalmol. 2021. PMID: 32338527

4

Predictors of 24-month onset of macular fibrosis in type 3 macular neovascularisation.

Forte P, Fontana V, Muzio J, Di Cello L, Corazza P, Rosa R, Musetti D, Vagge A, Traverso CE, Nicolò M. Forte P, et al. Among authors: corazza p. Br J Ophthalmol. 2024 Aug 22;108(9):1240-1248. doi: 10.1136/bjo-2023-324713. Br J Ophthalmol. 2024. PMID: 38290807

5

Prechoroidal Cleft Regression After Switch to Intravitreal Brolucizumab.

Forte P, Ferro Desideri L, Manocchio R, Corazza P, Traverso CE, Nicolò M. Forte P, et al. Among authors: corazza p. Eur J Ophthalmol. 2024 Jan;34(1):NP123-NP126. doi: 10.1177/11206721231185903. Epub 2023 Jul 6. Eur J Ophthalmol. 2024. PMID: 37415410

6

Ocular biometric parameters changes and choroidal vascular abnormalities in patients with neurofibromatosis type 1 evaluated by OCT-A.

Vagge A, Corazza P, Ferro Desideri L, Camicione P, Agosto G, Vagge R, Maria Grazia C, Carnevali A, Giannaccare G, Nicolò M, Traverso CE. Vagge A, et al. Among authors: corazza p. PLoS One. 2021 May 6;16(5):e0251098. doi: 10.1371/journal.pone.0251098. eCollection 2021. PLoS One. 2021. PMID: 33956880 Free PMC article.

7

The upcoming role of Artificial Intelligence (AI) for retinal and glaucomatous diseases.

Ferro Desideri L, Rutigliani C, Corazza P, Nastasi A, Roda M, Nicolo M, Traverso CE, Vagge A. Ferro Desideri L, et al. Among authors: corazza p. J Optom. 2022;15 Suppl 1(Suppl 1):S50-S57. doi: 10.1016/j.optom.2022.08.001. Epub 2022 Oct 8. J Optom. 2022. PMID: 36216736 Free PMC article. Review.

8

The Eye, Oxidative Damage and Polyunsaturated Fatty Acids.

Saccà SC, Cutolo CA, Ferrari D, Corazza P, Traverso CE. Saccà SC, et al. Among authors: corazza p. Nutrients. 2018 May 24;10(6):668. doi: 10.3390/nu10060668. Nutrients. 2018. PMID: 29795004 Free PMC article. Review.

9

Biometric and refractive errors evaluation in patients with neurofibromatosis type 1.

Vagge A, Corazza P, Vagge R, Agosto G, Iester M, Camicione P, Ferro Desideri L, Traverso CE. Vagge A, et al. Among authors: corazza p. Eur J Ophthalmol. 2021 May;31(3):938-942. doi: 10.1177/1120672120934402. Epub 2020 Jun 9. Eur J Ophthalmol. 2021. PMID: 32515611

10

Substances of Interest That Support Glaucoma Therapy.

Saccà SC, Corazza P, Gandolfi S, Ferrari D, Sukkar S, Iorio EL, Traverso CE. Saccà SC, et al. Among authors: corazza p. Nutrients. 2019 Jan 22;11(2):239. doi: 10.3390/nu11020239. Nutrients. 2019. PMID: 30678262 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters